Witnesses saw the victim being attacked by a group of people in the Tenderloin, officials said.
Screenshot of the corner of Golden Gate Avenue and Hyde Street, where Faheem Carter was attacked Saturday night.A local activist suffered life-threatening injuries when he was attacked by a group of people and then struck by a vehicle inWitnesses reported seeing 30-year-old Faheem Carter being attacked by numerous unknown suspects near the area of Golden Gate Avenue and Hyde Street on Saturday night, a San Francisco Police Department spokesperson told SFGATE.
Carter is a celebrated activist known for co-founding the Florence Fang Community Farm in Bayview-Hunters Point, San Francisco's largest community garden. Prior to the attack, he had received an award at City Hall for his work, according to a
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How CBRE Group Inc. is reexamining its own office space - San Francisco Business TimesThe Business Journals recently caught up with Peter Van Emburgh, senior vice president and global head of real estate at CBRE Group Inc., in the company's Atlanta office. Van Emburgh oversees about 7 million square feet of office space across 600 locations globally for CBRE.
Read more »
How to increase productivity for workers - San Francisco Business TimesAfter surging in 2020 and 2021, worker productivity is slipping. Experts say there are some strategies for reversing the trend.
Read more »
Satsuma stock sinks after migraine trial flop - San Francisco Business TimesThe company was developing a nasal dry-powder spray, and it thinks study data show the drug-device will work — but another company likely will take it the rest of the way.
Read more »
24th Street BART station in San Francisco closed after tracks start smokingThe 24th Street BART station has closed after there were reports of smoke seen coming from the tracks Monday evening, according to transit officials.
Read more »
Genentech Alzheimer's drug gantenerumab fails 2 late-stage clinical trials - San Francisco Business TimesThe trial failures are the latest disappointments in the Alzheimer's Disease space, especially those promising to have an impact on the memory-robbing disease by removing clumps of the protein beta-amyloid.
Read more »
Scilex Holding Co. is Bay Area's 14th SPAC merger of 2022 - San Francisco Business TimesShares of the developer of non-opiod pain treatments rose modestly on their Friday debut and see-sawed to a bigger gain on Tuesday.
Read more »